Metabolic Rewiring Emerges as Key Strategy to Help CAR-T Cells Survive and Destroy Solid Tumors

Researchers are "reprogramming" the metabolism of CAR-T cells to help them survive nutrient-poor solid tumors and avoid cellular exhaustion.

By: AXL Media

Published: Apr 30, 2026, 5:01 AM EDT

Source: Information for this report was sourced from News Medical Life Sciences and Cell Communication and Signaling

Engineered Immune Cells Face Hostile Nutrient Competition

While CAR-T cell therapy has achieved landmark success in treating liquid blood cancers, its effectiveness against solid tumors has been severely hampered by the "metabolic barrier" of the tumor microenvironment. Solid tumors are notoriously hostile environments that deprive infiltrating immune cells of the essential nutrients they need to survive and function. Cancer cells aggressively consume glucose, lipids, and amino acids, leaving engineered T cells in a state of starvation. This nutrient competition, combined with a buildup of toxic metabolic byproducts like lactate, often leads to rapid T-cell exhaustion and the ultimate failure of the treatment. A new review published in Cell Communication and Signaling on April 29, 2026, details how "rewiring" the internal metabolism of these cells may finally allow them to conquer these immunosuppressive landscapes.

Glucose Reprogramming to Sustain High-Intensity Killing

Glucose serves as the primary fuel for the tumor-killing activity of activated T cells. To ensure that CAR-T cells can compete with gluttonous cancer cells, researchers are testing ways to enhance glucose uptake. One promising strategy involves overexpressing Glucose Transporter Type 1 (GLUT1) or utilizing more efficient transporters like GLUT3, which allow the T cells to scavenge sugar even in low-glucose environments. Additionally, "metabolic priming" during the manufacturing stage can create memory-like cells that are more resilient. By using pharmacological agents to target metabolic enzymes, scientists can boost mitochondrial function, ensuring that the CAR-T cells maintain their energy production and cytotoxicity even when the tumor attempts to starve them out.

Lipid Metabolism and the Quest for Long-Term Persistence

Beyond immediate killing, the long-term persistence of CAR-T cells—their ability to stay in the body and prevent relapse—is heavily dependent on lipid metabolism. Research indicates that T cells relying on fatty acid oxidation (FAO) show much greater durability. The choice of costimulatory domains during the CAR design process is critical here; for instance, 4-1BB-based designs tend to favor lipid-based energy production and longevity, whereas CD28-based designs focus more on rapid sugar consumption. Innovative approaches, including the use of ultra-high-dose-rate (FL...